Alzamend Neuro Inc ALZN:NASDAQ

RT Quote | USD
Last | 05/20/24 EDT
0.6298UNCH (UNCH)
Volume
18,759
52 week range
0.44 - 11.91
Loading...
  • Open0.6311
  • Day High0.68
  • Day Low0.62
  • Prev Close0.6335
  • 52 Week High11.91
  • 52 Week High Date06/01/23
  • 52 Week Low0.44
  • 52 Week Low Date05/07/24

Key Stats

  • Market Cap4.333M
  • Shares Out6.88M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.01
  • YTD % Change-29.24

KEY STATS

  • Open0.6311
  • Day High0.68
  • Day Low0.62
  • Prev Close0.6335
  • 52 Week High11.91
  • 52 Week High Date06/01/23
  • 52 Week Low0.44
  • 52 Week Low Date05/07/24
  • Market Cap4.333M
  • Shares Out6.88M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.01
  • YTD % Change-29.24

RATIOS/PROFITABILITY

  • EPS (TTM)-2.32
  • P/E (TTM)-0.27
  • Fwd P/E (NTM)-0.33
  • EBITDA (TTM)-15.12M
  • ROE (TTM)-496.81%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/24/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alzamend Neuro Inc

 

Profile

MORE
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and...
William Horne
Chairman of the Board
Milton Ault III
Vice Chairman of the Board
Stephan Jackman
Chief Executive Officer, Director
David Katzoff
Chief Financial Officer
Henry Nisser
Executive Vice President, General Counsel, Director
Address
3480 Peachtree Road NE
, Second Floor, Suite 103
Atlanta, GA
30326
United States

Top Peers

SYMBOLLASTCHG%CHG
GLTO
Galecto Inc
0.6131UNCHUNCH
NERV
Minerva Neurosciences Inc
2.46UNCHUNCH
TRAW
Traws Pharma Inc
0.653UNCHUNCH
EVAX
Evaxion Biotech A/S
3.57UNCHUNCH
GLYC
GlycoMimetics Inc
0.2754UNCHUNCH